Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc  

(Public, LON:GSK)   Watch this stock  
Find more results for GSK
1,304.30
+9.30 (0.72%)
Dec 18 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 1,296.50 - 1,314.50
52 week 1,270.00 - 1,724.50
Open 1,300.00
Vol / Avg. 9.20M/10.07M
Mkt cap 64.15B*
P/E 27.45
Div/yield 19.00*
EPS 0.48*
Shares 4.96B
Beta     -
Inst. own     -
*GBP
Feb 7, 2018
Q4 2017 GlaxoSmithKline PLC Earnings Release Add to calendar
Dec 12, 2017
GlaxoSmithKline PLC to Discuss Anti-BCMA (B-cell Maturation Antigen) Antibody-Drug Conjugate Call
Oct 25, 2017
Q3 2017 GlaxoSmithKline PLC Earnings Call - Webcast
Oct 25, 2017
Q3 2017 GlaxoSmithKline PLC Earnings Release
  

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin 17.79% 3.81%
Operating margin 24.03% 9.32%
EBITD margin - 33.06%
Return on average assets 9.56% 1.89%
Return on average equity 461.88% 29.24%
Employees 99,827 -
CDP Score - A

Address

980 Great West Road
BRENTFORD, TW8 9GS
United Kingdom - Map
+44-20-80475000 (Phone)
+44-20-80477807 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines, vaccines and consumer healthcare products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. The Consumer Healthcare business develops and markets products in Wellness, Oral health, Nutrition and Skin health categories. Its product portfolio includes Adartrel, Bexsero, Daraprim and Quinvaxem. Its brands include Panadol, abreva, polident and physiogel.

Officers and directors

Emma Walmsley Chief Executive Officer, Executive Director
Age: 47
Simon Dingemans Chief Financial Officer, Executive Director
Age: 53
Patrick Vallance President - R&D, Executive Director
Age: 56
Roger Connor President - Global Manufacturing & Supply
Luc Debruyne President - Global Vaccines
Abbas Hussain President - Global Pharmaceuticals
Shah Abbas Hussain President - Global Pharmaceuticals
Brian McNamara Chief Executive Officer - GSK Consumer Healthcare
Age: 50
Luke Miels President - Global Pharmaceuticals
Daniel E. Troy Senior Vice President, General Counsel